EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris

Jan-Christoph Walter, Ann-Kathrin Kissmann iD, Daniel Gruber, Daniel Alpízar-Pedraza iD, Ernesto M Martell-Huguet, Nico Preising, Armando Rodriguez-Alfonso iD, Ludger Ständker iD, Christoph Kleber iD, Wolfgang Knoll iD, Steffen Stenger, Carolina Firacative iD und 1 weitere

Biomolecules · 2025

DOI: 10.3390/biom15030322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Jan-Christoph Walter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany. Hauptthemen laut MEDLINE: Biofilms, Candida albicans, Candida parapsilosis, Antifungal Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Alexander von Humboldt Foundation, German Academic Exchange Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilms are the predominant lifeforms of microorganisms, contributing to over 80% of infections, including those caused by Candida species like C. albicans, C. parapsilosis and Candidozyma auris. These species form biofilms on medical devices, making infections challenging to treat, especially with the rise in drug-resistant strains. Candida infections, particularly hospital-acquired ones, are a significant health threat due to their resistance to antifungals and the risk of developing systemic infections (i.e., sepsis). We have previously shown that C14R reduces the viability of C. albicans and C. auris, but not of C. parapsilosis. Here, we show that C14R not only inhibits viability by pore formation, shown in a resazurin reduction assay, and in a C. parapsilosis and fluorescence-based permeabilization assay, but it also halts biofilm maturation and significantly reduces the biomass of preformed biofilms by over 70%. These findings suggest C14R could be an effective option for treating severe fungal infections, offering a potential new treatment approach for biofilm-related diseases. Further research is needed to fully understand its biofilm dispersal potential and to optimize its use for future applications as an antifungal in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsCandida albicansCandida parapsilosisAntifungal AgentsCandida aurisAntimicrobial PeptidesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

infectious diseasenext-generation antimycoticnovel antifungals

Substanzen

Antifungal AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • Institute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
  • Center for Pharmaceutical Research and Development (CIDEM), 26th Avenue, No. 1605, Nuevo Vedado, La Habana 10400, Cuba.
  • Core Facility for Functional Peptidomics (CFP), Faculty of Medicine, Ulm University, 89081 Ulm, Germany.
  • Core Unit of Mass Spectrometry and Proteomics, Faculty of Medicine, Ulm University, 89081 Ulm, Germany.
  • Faculty of Medicine and Dentistry, Danube Private University, Steiner Landstraße 124, 3500 Krems an der Donau, Austria.
  • Institute for Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.

ORCID-Profile: Ann-Kathrin Kissmann, Daniel Alpízar-Pedraza, Armando Rodriguez-Alfonso, Ludger Ständker, Christoph Kleber, Wolfgang Knoll, Carolina Firacative, Frank Rosenau

Förderung

  • Deutsche Forschungsgemeinschaft
  • Alexander von Humboldt Foundation
  • German Academic Exchange Service
  • Gesellschaft für Forschungsförderung Niederösterreich
  • Austrian Research Promotion Agency
  • German Research Society (DFG)
  • Alexander von Humboldt-Stiftung, Research Group Linkage Program
  • DAAD-Germany

Zitieren

APA

Walter, J. C., Kissmann, A. K., Gruber, D., Alpízar-Pedraza, D., Martell-Huguet, E. M., Preising, N., Rodriguez-Alfonso, A., Ständker, L., Kleber, C., Knoll, W., Stenger, S., Firacative, C., & Rosenau, F. (2025). Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris. Biomolecules. https://doi.org/10.3390/biom15030322

Vancouver

Walter JC, Kissmann AK, Gruber D, Alpízar-Pedraza D, Martell-Huguet EM, Preising N, et al. Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris. Biomolecules. 2025. doi:10.3390/biom15030322

BibTeX
@article{Walter2025,
  author = {Walter, Jan-Christoph and Kissmann, Ann-Kathrin and Gruber, Daniel and Alpízar-Pedraza, Daniel and Martell-Huguet, Ernesto M and Preising, Nico and Rodriguez-Alfonso, Armando and Ständker, Ludger and Kleber, Christoph and Knoll, Wolfgang and Stenger, Steffen and Firacative, Carolina and Rosenau, Frank},
  title = {Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15030322}
}
Kostenlos starten →